Literature DB >> 1850050

The 5'-terminal nucleotides of hepatitis A virus RNA, but not poliovirus RNA, are required for infectivity.

S A Harmon1, O C Richards, D F Summers, E Ehrenfeld.   

Abstract

A series of plasmids containing hepatitis A virus (HAV) cDNA was constructed such that positive-strand HAV RNA could be transcribed with T7 RNA polymerase. The plasmids differed in the number of 5'-terminal nucleotides representing the junctions between vectors and HAV sequences that were present in the transcripts. When these transcripts were used to transfect cultured BS-C-1 cells, it was found that only those transcripts that contained all of the 5'-terminal HAV nucleotides, in addition to one or more nucleotides from the vector, were capable of initiating an infectious cycle leading to production of progeny virus. Transcripts that contained one 5'-terminal nucleotide from the vector sequence but were missing two uridylate residues corresponding to the first two nucleotides of HAV sequences, or were missing U and C residues corresponding to nucleotides 2 and 3 of the HAV sequence, were not infectious. A similar plasmid containing poliovirus cDNA was engineered to produce transcripts similarly lacking the first two uridylate residues of the poliovirus RNA sequence. These transcripts were infectious.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1850050      PMCID: PMC240644     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  An improved method for sequencing of RNA templates.

Authors:  O Fichot; M Girard
Journal:  Nucleic Acids Res       Date:  1990-10-25       Impact factor: 16.971

2.  Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase.

Authors:  S van der Werf; J Bradley; E Wimmer; F W Studier; J J Dunn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

3.  Initiation of poliovirus plus-strand RNA synthesis in a membrane complex of infected HeLa cells.

Authors:  N Takeda; R J Kuhn; C F Yang; T Takegami; E Wimmer
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

4.  A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation.

Authors:  S K Jang; H G Kräusslich; M J Nicklin; G M Duke; A C Palmenberg; E Wimmer
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

5.  Comparative sequence analysis of the 5' noncoding region of the enteroviruses and rhinoviruses.

Authors:  V M Rivera; J D Welsh; J V Maizel
Journal:  Virology       Date:  1988-07       Impact factor: 3.616

6.  Classification of hepatitis A virus as enterovirus type 72 and of hepatitis B virus as hepadnavirus type 1.

Authors:  J L Melnick
Journal:  Intervirology       Date:  1982       Impact factor: 1.763

7.  Poliovirus temperature-sensitive mutant containing a single nucleotide deletion in the 5'-noncoding region of the viral RNA.

Authors:  V R Racaniello; C Meriam
Journal:  Virology       Date:  1986-12       Impact factor: 3.616

8.  Hepatitis A virus cDNA and its RNA transcripts are infectious in cell culture.

Authors:  J I Cohen; J R Ticehurst; S M Feinstone; B Rosenblum; R H Purcell
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

9.  Expression of hepatitis A virus capsid sequences in insect cells.

Authors:  S A Harmon; J M Johnston; T Ziegelhoffer; O C Richards; D F Summers; E Ehrenfeld
Journal:  Virus Res       Date:  1988-05       Impact factor: 3.303

10.  Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA.

Authors:  J Pelletier; N Sonenberg
Journal:  Nature       Date:  1988-07-28       Impact factor: 49.962

View more
  26 in total

1.  Poliovirus requires a precise 5' end for efficient positive-strand RNA synthesis.

Authors:  J Herold; R Andino
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Identification of an RNA hairpin in poliovirus RNA that serves as the primary template in the in vitro uridylylation of VPg.

Authors:  A V Paul; E Rieder; D W Kim; J H van Boom; E Wimmer
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

Review 3.  Non-template functions of viral RNA in picornavirus replication.

Authors:  Sushma A Ogram; James B Flanegan
Journal:  Curr Opin Virol       Date:  2011-11       Impact factor: 7.090

4.  Export and transport of tRNA are coupled to a multi-protein complex.

Authors:  C Kruse; D K Willkomm; A Grünweller; T Vollbrandt; S Sommer; S Busch; T Pfeiffer; J Brinkmann; R K Hartmann; P K Müller
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

5.  3'-Terminal sequence in poliovirus negative-strand templates is the primary cis-acting element required for VPgpUpU-primed positive-strand initiation.

Authors:  Nidhi Sharma; Brian J O'Donnell; James B Flanegan
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

6.  An authentic 3' noncoding region is necessary for efficient poliovirus replication.

Authors:  David M Brown; Christopher T Cornell; Genevieve P Tran; Joseph H C Nguyen; Bert L Semler
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  Proteolytic activity of hepatitis A virus 3C protein.

Authors:  X Y Jia; E Ehrenfeld; D F Summers
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

8.  trans-encapsidation of a poliovirus replicon by different picornavirus capsid proteins.

Authors:  X Y Jia; M Van Eden; M G Busch; E Ehrenfeld; D F Summers
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

9.  Amplification of the full-length hepatitis A virus genome by long reverse transcription-PCR and transcription of infectious RNA directly from the amplicon.

Authors:  R Tellier; J Bukh; S U Emerson; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

10.  Interaction of poly(rC) binding protein 2 with the 5' noncoding region of hepatitis A virus RNA and its effects on translation.

Authors:  J Graff; J Cha; L B Blyn; E Ehrenfeld
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.